Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 2/2017

30.09.2016 | Head and Neck

The development of an ICF-based clinical guideline and screening tool for the standardized assessment and evaluation of functioning after head and neck cancer treatment

verfasst von: Ulrich Kisser, Christine Adderson-Kisser, Michaela Coenen, Marita Stier-Jarmer, Sven Becker, Carla Sabariego, Ulrich Harréus

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

The assessment and evaluation of functioning and quality of life after tumor treatment in head and neck cancer (HNC) are considered as essential aspects of clinical routine and studies. A huge number of instruments are available that have been designed to evaluate functioning and quality of life after HNC treatment. The diversity of these instruments in terms of content, response options and administration hinders the comparability of available studies and the performance of meta-analyses. The objective of this paper is to inform about the development of a screening tool for the standardized assessment and evaluation of functioning based on the International Classification of Functioning, Disability and Health (ICF) Core Set for HNC. We followed a multi-step approach including (1) preparatory studies to identify and preselect suitable instruments for the assessment of functioning, (2) a decision-making process to agree on an ICF-based clinical guideline including instruments assessing functioning and (3) the development of a computer-based standardized screening tool to assess and evaluate functioning based on this guideline in clinical routine. Twenty-one experts participated in a consensus meeting and decided on instruments to be included in an ICF-based clinical guideline and screening tool for the assessment and evaluation of functioning in HNC patients in cancer treatment. The chosen instruments cover all aspects of the ICF Core Set for HNC addressing therapy control, pain, food intake/swallowing, voice/speech/breathing, other somatic complaints and psychosocial aspects. The screening tool contains patient-reported outcome measures and a clinician’s checklist. It has to be further tested in clinical practice.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Bjordal K, Ahlner-Elmqvist M, Hammerlid E, Boysen M, Evensen JF, Biörklund A, Jannert M, Westin T, Kaasa S (2001) A prospective study of quality of life in head and neck cancer patients. Part II: longitudinal data. Laryngoscope 111(8):1440–1452CrossRefPubMed Bjordal K, Ahlner-Elmqvist M, Hammerlid E, Boysen M, Evensen JF, Biörklund A, Jannert M, Westin T, Kaasa S (2001) A prospective study of quality of life in head and neck cancer patients. Part II: longitudinal data. Laryngoscope 111(8):1440–1452CrossRefPubMed
3.
Zurück zum Zitat Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Oudinot P, Calais G (2003) Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. Int J Radiat Oncol Biol Phys 55(1):93–98. doi:10.1016/S0360-3016(02)03819-1 CrossRefPubMed Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Oudinot P, Calais G (2003) Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. Int J Radiat Oncol Biol Phys 55(1):93–98. doi:10.​1016/​S0360-3016(02)03819-1 CrossRefPubMed
4.
Zurück zum Zitat Langmore S, Krisciunas G (2010) Dysphagia after radiotherapy for head and neck cancer: etiology, clinical presentation, and efficacy of current treatments. Perspect Swallowing Swallowing Disord (Dysphagia) 19(2):32–38. doi:10.1044/sasd19.2.32 CrossRef Langmore S, Krisciunas G (2010) Dysphagia after radiotherapy for head and neck cancer: etiology, clinical presentation, and efficacy of current treatments. Perspect Swallowing Swallowing Disord (Dysphagia) 19(2):32–38. doi:10.​1044/​sasd19.​2.​32 CrossRef
6.
Zurück zum Zitat Vissink A, Mitchell JB, Baum BJ, Limesand KH, Jensen SB, Fox PC, Elting LS, Langendijk JA, Coppes RP, Reyland ME (2010) Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers. Int J Radiat Oncol Biol Phys 78(4):983–991. doi:10.1016/j.ijrobp.2010.06.052 CrossRefPubMedPubMedCentral Vissink A, Mitchell JB, Baum BJ, Limesand KH, Jensen SB, Fox PC, Elting LS, Langendijk JA, Coppes RP, Reyland ME (2010) Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers. Int J Radiat Oncol Biol Phys 78(4):983–991. doi:10.​1016/​j.​ijrobp.​2010.​06.​052 CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Chaplin JM, Morton RP (1999) A prospective, longitudinal study of pain in head and neck cancer patients. Head Neck 21(6):531–537CrossRefPubMed Chaplin JM, Morton RP (1999) A prospective, longitudinal study of pain in head and neck cancer patients. Head Neck 21(6):531–537CrossRefPubMed
9.
Zurück zum Zitat Rogers SN, Harvey-Woodworth CN, Hare J, Leong P, Lowe D (2012) Patients´ perception of the financial impact of head and neck cancer and the relationship to health related quality of life. Br J Oral Maxillofac Surg 50(5):410–416. doi:10.1016/j.bjoms.2011.07.026 CrossRefPubMed Rogers SN, Harvey-Woodworth CN, Hare J, Leong P, Lowe D (2012) Patients´ perception of the financial impact of head and neck cancer and the relationship to health related quality of life. Br J Oral Maxillofac Surg 50(5):410–416. doi:10.​1016/​j.​bjoms.​2011.​07.​026 CrossRefPubMed
12.
Zurück zum Zitat Bozec A, Poissonnet G, Chamorev E, Casanova C, Laout C, Vallicioni J, Demard F, Peyrade F, Follana P, Bensadoun RJ, Benezery K, Thariat J, Marcy PY, Sudaka A, Weber P, Dassonville O (2009) Quality of life after oral and oropharyngeal reconstruction with a radial forearm free flap: prospective study. J Otolaryngol Head Neck Surg 38(3):401–408PubMed Bozec A, Poissonnet G, Chamorev E, Casanova C, Laout C, Vallicioni J, Demard F, Peyrade F, Follana P, Bensadoun RJ, Benezery K, Thariat J, Marcy PY, Sudaka A, Weber P, Dassonville O (2009) Quality of life after oral and oropharyngeal reconstruction with a radial forearm free flap: prospective study. J Otolaryngol Head Neck Surg 38(3):401–408PubMed
16.
Zurück zum Zitat Tschiesner U, Rogers SN, Harreus U, Berghaus A, Cieza A (2009) Comparison of outcome measures in head and neck cancer: a literature review 2000–2006. Head Neck 31(2):251–259. doi:10.1002/hed.20960 CrossRefPubMed Tschiesner U, Rogers SN, Harreus U, Berghaus A, Cieza A (2009) Comparison of outcome measures in head and neck cancer: a literature review 2000–2006. Head Neck 31(2):251–259. doi:10.​1002/​hed.​20960 CrossRefPubMed
17.
Zurück zum Zitat Paleri V, Thomas L, Basavaiah N, Drinnan M, Mehanna H, Jones T (2011) Oncologic outcomes of open conservation laryngectomy for radiorecurrent laryngeal carcinoma. Cancer 117(12):2668–2676. doi:10.1002/cncr.25831 CrossRefPubMed Paleri V, Thomas L, Basavaiah N, Drinnan M, Mehanna H, Jones T (2011) Oncologic outcomes of open conservation laryngectomy for radiorecurrent laryngeal carcinoma. Cancer 117(12):2668–2676. doi:10.​1002/​cncr.​25831 CrossRefPubMed
19.
Zurück zum Zitat Wright EP, Selby PJ, Crawford M, Gillibrand A, Johnston C, Perren TJ, Rush R, Smith A, Velikova G, Watson K, Gould A (2003) Feasibility and compliance of automated measurement of quality of life in oncology practice. J Clin Oncol 21(2):374–382CrossRefPubMed Wright EP, Selby PJ, Crawford M, Gillibrand A, Johnston C, Perren TJ, Rush R, Smith A, Velikova G, Watson K, Gould A (2003) Feasibility and compliance of automated measurement of quality of life in oncology practice. J Clin Oncol 21(2):374–382CrossRefPubMed
20.
Zurück zum Zitat World Health Organization (2001) International classification of functioning, disability and health: ICF. WHO, Geneva World Health Organization (2001) International classification of functioning, disability and health: ICF. WHO, Geneva
21.
22.
Zurück zum Zitat Tschiesner U, Linseisen E, Becker S, Mast G, Rogers SN, Walvekar RR, Berghaus A, Cieza A (2010) Content validation of the International Classification of Functioning, Disability and Health Core Sets for Head and Neck Cancer: A Multicentre Study. J Otolaryngol Head Neck Surg 39(6):674–687PubMed Tschiesner U, Linseisen E, Becker S, Mast G, Rogers SN, Walvekar RR, Berghaus A, Cieza A (2010) Content validation of the International Classification of Functioning, Disability and Health Core Sets for Head and Neck Cancer: A Multicentre Study. J Otolaryngol Head Neck Surg 39(6):674–687PubMed
23.
24.
Zurück zum Zitat Kirschneck M, Sabariego C, Singer S, Tschiesner U (2014) Assessment of functional outcomes in patients with head and neck cancer according to the International Classification of Functioning, Disability and Health Core Sets from the perspective of the multi-professional team: Results of 4 Delphi surveys. Head Neck 36(7):954–968. doi:10.1002/hed.23399 CrossRefPubMed Kirschneck M, Sabariego C, Singer S, Tschiesner U (2014) Assessment of functional outcomes in patients with head and neck cancer according to the International Classification of Functioning, Disability and Health Core Sets from the perspective of the multi-professional team: Results of 4 Delphi surveys. Head Neck 36(7):954–968. doi:10.​1002/​hed.​23399 CrossRefPubMed
26.
Zurück zum Zitat Engelbarts M, Holtfreter V, Kisser U, Sabariego C, Stier-Jarmer M, Coenen M, Ernst BP, Strieth S, Harréus UA, Becker S Content validation of the Comprehensive ICF Core Set for Head and Neck Cancer: The perspective of speech and language therapists. In peer review Engelbarts M, Holtfreter V, Kisser U, Sabariego C, Stier-Jarmer M, Coenen M, Ernst BP, Strieth S, Harréus UA, Becker S Content validation of the Comprehensive ICF Core Set for Head and Neck Cancer: The perspective of speech and language therapists. In peer review
27.
Zurück zum Zitat Sneeuw KCA, Aaronson NK, Sprangers MAG, Detmar SB, Wever LDV, Schornagel JH (1998) Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. J Clin Epidemiol 51(7):617–631. doi:10.1016/S0895-4356(98)00040-7 CrossRefPubMed Sneeuw KCA, Aaronson NK, Sprangers MAG, Detmar SB, Wever LDV, Schornagel JH (1998) Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. J Clin Epidemiol 51(7):617–631. doi:10.​1016/​S0895-4356(98)00040-7 CrossRefPubMed
28.
Zurück zum Zitat Belafsky PC, Mouadeb DA, Rees CJ, Pryor JC, Postma GN, Allen J, Leonard RJ (2008) Validity and reliability of the Eating Assessment Tool (EAT-10). Ann Otol Rhinol Laryngol 117(12):919–924CrossRefPubMed Belafsky PC, Mouadeb DA, Rees CJ, Pryor JC, Postma GN, Allen J, Leonard RJ (2008) Validity and reliability of the Eating Assessment Tool (EAT-10). Ann Otol Rhinol Laryngol 117(12):919–924CrossRefPubMed
29.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, Haes JCJMd, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376. doi:10.1093/jnci/85.5.365 CrossRefPubMed Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, Haes JCJMd, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376. doi:10.​1093/​jnci/​85.​5.​365 CrossRefPubMed
32.
Zurück zum Zitat Verdonck-de Leeuw IM, de Bree R, Keizer AL, Houffelaar T, Cuijpers P, van der Linden MH, Leemans CR (2009) Computerized prospective screening for high levels of emotional distress in head and neck cancer patients and referral rate to psychosocial care. Oral Oncol 45(10):e129–e133. doi:10.1016/j.oraloncology.2009.01.012 CrossRefPubMed Verdonck-de Leeuw IM, de Bree R, Keizer AL, Houffelaar T, Cuijpers P, van der Linden MH, Leemans CR (2009) Computerized prospective screening for high levels of emotional distress in head and neck cancer patients and referral rate to psychosocial care. Oral Oncol 45(10):e129–e133. doi:10.​1016/​j.​oraloncology.​2009.​01.​012 CrossRefPubMed
33.
Zurück zum Zitat Tschiesner U, Linseisen E, Coenen M, Rogers S, Harreus U, Berghaus A, Cieza A (2009) Evaluating sequelae after head and neck cancer from the patient perspective with the help of the International Classification of Functioning. Disability and Health. Eur Arch Otorhinolaryngol 266(3):425–436. doi:10.1007/s00405-008-0764-z CrossRefPubMed Tschiesner U, Linseisen E, Coenen M, Rogers S, Harreus U, Berghaus A, Cieza A (2009) Evaluating sequelae after head and neck cancer from the patient perspective with the help of the International Classification of Functioning. Disability and Health. Eur Arch Otorhinolaryngol 266(3):425–436. doi:10.​1007/​s00405-008-0764-z CrossRefPubMed
Metadaten
Titel
The development of an ICF-based clinical guideline and screening tool for the standardized assessment and evaluation of functioning after head and neck cancer treatment
verfasst von
Ulrich Kisser
Christine Adderson-Kisser
Michaela Coenen
Marita Stier-Jarmer
Sven Becker
Carla Sabariego
Ulrich Harréus
Publikationsdatum
30.09.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 2/2017
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-016-4317-6

Weitere Artikel der Ausgabe 2/2017

European Archives of Oto-Rhino-Laryngology 2/2017 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.